HAMBURG (dpa-AFX Broker) - Analyst firm Warburg Research has left its rating for Drägerwerk at "Buy" with a target price of 62 euros after key data for 2023 and an outlook for 2024. The medical and safety technology group exceeded expectations for 2023, analyst Christian Ehmann wrote in a study published on Tuesday. The company's outlook is in line with his expectations./mis/la
Publication of the original study: 16.01.2024 / 08:15 / CET
First dissemination of the original study: 16.01.2024 / Time not specified in study / CET
-----------------------
dpa-AFX Broker - the Trader News from dpa-AFX
-----------------------